NCT05149885View on ClinicalTrials.gov

A Feasibility Study of SenseGuard to Assess Airway Responsiveness During Methacholine Challenge Test (MCT)

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 4, 2021

Primary Completion Date

March 25, 2023

Study Completion Date

June 1, 2023

Conditions
Asthma
Interventions
DEVICE

SenseGuard monitoring

All subjects that recruited to the study will undergo MCT as usual with the addition of SG measurement after each Methacholine dose and spirometry test.

Trial Locations (1)

Unknown

Nicosia Lung Center, Nicosia

Sponsors

Lead Sponsor

NanoVation
All Listed Sponsors
lead

NanoVation

INDUSTRY

NCT05149885 - A Feasibility Study of SenseGuard to Assess Airway Responsiveness During Methacholine Challenge Test (MCT) | Biotech Hunter | Biotech Hunter